Mutual Fund Details

Edelweiss Recently Listed IPO Fund Direct - Growth

Equity Themed

NAV

₹25.0755

as on 16 May 2024, 11:45 PM

₹0.0795(0.32%)

Last Change

Schemes Managed By

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,56,819

₹1,63,039

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹63,039

Profit (absolute return)

63.04%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

3.40%

In the last 6 months

11.40%

In the last 1 year

40.28%

In the last 3 years

63.04%

In the last 5 years

185.37%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Edelweiss Recently Listed IPO Fund Direct - Growth

as of 30 Jun 2023, 05:30 AM

₹930.71 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 2% if redeemed within 6 months.

0.97%

Expense Ratio

Plan

Growth

0.86%

Cash Holding

Benchmark

India Recent 100 IPO TRI

Scheme Document

View

Benchmark

India Recent 100 IPO TRI

Exit Load

Exit load of 2% if redeemed within 6 months.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Jun 2023

Sort By

Value

Sector

Healthcare

20.08%

₹186.85 Cr

Services

17.36%

₹161.58 Cr

Financial

17.00%

₹158.19 Cr

Capital Goods

15.23%

₹141.74 Cr

Consumer Staples

6.93%

₹64.51 Cr

Others

23.41%

₹217.88 Cr

View All

Sectors Holding in this Mutual Fund

as on 30 Jun 2023

Sort By

Value

Sector

Healthcare

20.08%

₹186.85 Cr

Services

17.36%

₹161.58 Cr

Financial

17.00%

₹158.19 Cr

Capital Goods

15.23%

₹141.74 Cr

Consumer Staples

6.93%

₹64.51 Cr

Others

23.41%

₹217.88 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Jun 2023

Sort By

Value

Company

Global Health Ltd.

4.81%

₹44.77 Cr

KFin Technologies Ltd.

4.64%

₹43.18 Cr

Mankind Pharma Ltd.

4.24%

₹39.46 Cr

Concord Biotech Ltd.

3.85%

₹35.83 Cr

JSW Infrastructure Ltd.

3.49%

₹32.48 Cr

Others

78.97%

₹734.98 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Jun 2023

Sort By

Value

Company

Global Health Ltd.

4.81%

₹44.77 Cr

KFin Technologies Ltd.

4.64%

₹43.18 Cr

Mankind Pharma Ltd.

4.24%

₹39.46 Cr

Concord Biotech Ltd.

3.85%

₹35.83 Cr

JSW Infrastructure Ltd.

3.49%

₹32.48 Cr

Others

78.97%

₹734.98 Cr

View All

Funds in this Category

This fund's returns:

17.66%

Return Duration

3 Years

Quant Quantamental Fund Direct - Growth

ICICI Prudential Manufacturing Fund Direct - Growth

Franklin India Opportunities Direct Fund-Growth

About Edelweiss Recently Listed IPO Fund Direct - Growth

Edelweiss Recently Listed IPO Fund Direct - Growth is a Equity mutual fund scheme from Edelweiss Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund managers Bharat Lahoti and Bhavesh Jain. It has an AUM of ₹930.71 Crores and the latest NAV decalared is ₹25.076 as on 17 May 2024 at 7:19 am.

Edelweiss Recently Listed IPO Fund Direct - Growth scheme return performance in last 1 year is 40.28%, in last 3 years is 63.04% and 149.63% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.